Study: IUDs safe for teens; Medtronic launches new CRT implantation tech;

@FierceMedDev: Blood test reveals more vivid GI cancer gene mutations. More | Follow @FierceMedDev

@MarkHFierce: The U.K. govt is supporting development of an anti-obesity electronic implant, at Imperial College London. Report | Follow @MarkHFierce

 @DamianFierce: The AP has an excellent roundup of all that's happened with $ISRG over the past month or so. More | Follow @DamianFierce

> According to a study by the University of Texas, intrauterine devices are just as safe for teenagers as they are for adults, debunking long-believed myths about IUDs. More

> EndoEvolution, developer of minimally invasive suturing devices, closed a $5 million Series C. News

> Mallinckrodt, Covidien's ($COV) soon-to-be-spun-out drug business, is raising $900 million in senior notes to support the transition. Release

> IlluminOss Medical, maker of minimally invasive orthopedic systems, has appointed Dirk Kuyper president and CEO. Item

> Becton Dickinson ($BDX) won FDA clearance for its new C. difficile molecular diagnostic, using the BD Max assay platform. More

> CollabRx is teaming up with Sengenics to develop molecular diagnostics for the Asian market. News

> Medtronic ($MDT) has launched its CardioGuide implant system in the U.S. and Canada, touting the device as making the CRT implantation process easier and safer. Release

Biotech News

@FierceBiotech: FDA approved morning-sickness pill, to be marketed as Diclegis. Release | Follow @FierceBiotech

@JohnCFierce: Bristol-Myers' new R&D chief lays out PhIII game plan. More | Follow @JohnCFierce.

@RyanMFierce: Elsevier scoops up startup Mendeley in controversial bet on open science. Is it worth it? News | Follow @RyanMFierce

> Lundbeck touts promising head-to-head data on depression drug Brintellix. More

> NEA provides $10M to help fuel next-gen cancer R&D at Cleave. Report

> Gilead quickly asks FDA for blockbuster hep C approval. Story

Pharma News

@FiercePharma: CDC study finds U.S. adults still skipping their meds to save money. Until they qualify for Medicare. Report | Follow @FiercePharma

@EricPFierce: Fleming Laboratories has two plants in Pradesh, India, which were put on import alert Monday by the FDA. Alert | Follow @EricPFierce

> Amgen's two chiefs together net $22.7M in 2012 pay. More

> FDA approves morning-sickness drug withdrawn in 1980s safety scare. Item

> Union sues Warner Chilcott, Watson and Lupin over alleged pay-for-delay deal. Story

Pharma Manufacturing News

> China, India have yet to meet EU rule on APIs. More

> More Doxil made through J&J 'alternative manufacturing.' Report

> China drugmaker pulls flu treatment tainted with toxic herbs. Story

> Apotex recalls birth control pills. Article

Biotech Research News

@EmilyMFierce: Merck developing new class of drugs to target therapy-resistant cancer driven by genetic mutations. Report | Follow @EmilyMFierce

> Common sweetener mannitol improves motor functions in Parkinson's flies. More

> Targeted brain stimulation could treat addiction. Item

> New cancer radiation treatment has no harmful side effects in mice. Article

> Some still skeptical of BRAIN initiative as details remain fuzzy. Story

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.